A trial of carbamazepine in borderline personality disorder.
Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.
de la Fuente
J M
JM
Department of Psychiatry, Erasme Hospital, Free University of Brussels (ULB), Belgium.
Lotstra
F
F
D000328:Adult; D001519:Behavior; D001883:Borderline Personality Disorder / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales
D002220:Carbamazepine